Business

Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026

MARSEILLE, France, April 13, 2026--Number of shares and voting rights of Innate Pharma as of April 9, 2026

articleInnate Pharma Sa Class AApril 13, 20263/company/innate-pharma-sa-class-a/news/number-of-shares-and-voting-rights-of-innate-pharma-as-of-april-9-2026
Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026

About this update from Innate Pharma Sa Class A

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/0bf6d2d97508714b4d6cf9d3d22eefc9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OVd_dm.Is6zewx1F0DouFA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/0bf6d2d97508714b4d6cf9d3d22eefc9","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/sfG8Wi9bs7AGynYuYdPXzA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/0bf6d2d97508714b4d6cf9d3d22eefc9","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MARSEILLE, France, April 13, 2026--(BUSINESS WIRE)--Regulatory News:","length":68,"tagName":"p"},{"type":"text","content":"Pursuant to the article L. 233-8 II of the French "Code de Commerce" and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF") General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") releases its total number of shares outstanding as well as its voting rights as of April 9, 2026:","length":413,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;","val":[{"type":"text","content":"Total number of shares outstanding:","length":35,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","val":[]},{"colspan":"1","rowspan":"1","style":"padding-left:0.0px;padding-right:0.0px;vertical-align:bottom;text-align:right;list-style-position:inside;","val":[{"type":"text","content":"93,860,680","length":10,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","val":[]},{"colspan":"2","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;text-align:left;","val":[{"type":"text","content":"shares","length":6,"tagName":"p","attribs":{}}]}]},{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;padding-left:0.0px;","val":[{"type":"text","content":"including:","length":10,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","val":[]},{"colspan":"1","rowspan":"1","style":"padding-left:0.0px;padding-right:0.0px;vertical-align:bottom;text-align:right;list-style-position:insi...

More updates from Innate Pharma Sa Class A

Euronext ParisInnate PharmaAMFshares outstandingIPHvoting rightsNasdaqIPHA